SARAH POWELL: Open Payments
NPI 1326456054 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 47 payments from 14 companies in 2025. Trend: 2023 $123 · 2024 $657 · 2025 $1,220
Food & beverage: $1,220
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $319 |
| SK Life Science, Inc. | 5 | $303 |
| UCB, Inc. | 9 | $243 |
| Neurelis, Inc. | 2 | $75 |
| ACADIA Pharmaceuticals Inc | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Genentech USA, Inc. | 2 | $35 |
| Eisai Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: Fintepla, UBRELVY, QULIPTA, VYALEV, VALTOCO, Briviact, NUPLAZID, KESIMPTA.
Industry payments across TX — which companies pay providers there.
